Balchem Story

<div class='circular--portrait' style='background:#FF6600;color: #f7f7f7;font-size:4em;'>BC</div>
BCPC -- USA Stock  

USD 120.08  2.59  2.11%

Balchem Cp Net Income Per Employee is projected to decrease significantly based on the last few years of reporting. The past year's Net Income Per Employee was at 64,341.35. The current year Revenue Per Employee is expected to grow to about 652.4 K, whereas Average Assets are forecasted to decline to about 1 B. There are many examples of prices slipping after a drastic change in one of the technical indicators. In this short article, we will go over a few of Balchem Cp's essential fundamentals. What exactly are Balchem Cp shareholders getting in March? We currently estimate Balchem Cp as fairly valued. The real value is approaching 114.46 per share.
Published few days ago
View all stories for Balchem Cp | View All Stories
Will Balchem Cp (NASDAQ:BCPC) technical indicators remain weak in March?
Macroaxis provides advice on Balchem Cp to complement and cross-verify current analyst consensus on Balchem Cp. Our investment recommendation engine determines the company's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. This firm dividends can provide a clue to the current value of the stock. Balchem Cp one year expected dividend income is about $0.17 per share.
Typically, a company's financial statements are the reports that show the financial position of the company. There are three main documents that fall into the category of financial statements. These documents include Balchem Cp income statement, its balance sheet, and the statement of cash flows. Potential Balchem Cp investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Balchem Cp investors may use each financial statement separately, they are all related. The changes in Balchem Cp's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Balchem Cp's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
The goal of Balchem Cp fundamental analysis is to do accurate financial forecasts. There are several possible objectives to fundamental analysis, such as projecting of Balchem Cp performance into the future periods or doing a reasonable stock valuation. The intrinsic value of Balchem Cp shares is the value that is considered the true value of the share. If the intrinsic value Balchem is higher than its market price, buying is generally recommended. If it is equal to the market price, it is recommended to hold; and if it is less than the market price, then one should sell all shares Balchem Cp.
Please read more on our fundamental analysis page.

Are Balchem Cp Earnings Expected to grow?

The future earnings power of Balchem Cp involves the interaction of many company-specific, industry, and economic forces. Earnings estimates embody investors' opinions of Balchem Cp factors such as sales growth, product demand, competitive industry environment, profit margins, and cost controls. Balchem Cp stock prices adjust as these expectations change or are proven wrong. The main thing to remember is that equities with high expected earnings growth tend to underperform the market because it is usually difficult to meet the market's high expectations. Companies with low earnings expectations tend to do better than expected. Please use our latest analysis of Balchem expected earnings.

And What about dividends?

A dividend is the distribution of a portion of Balchem Cp earnings, decided and managed by the company's board of directors and paid to a class of its shareholders. Note, announcements of dividend payouts are generally accompanied by a proportional increase or decrease in a company's stock price. Balchem Cp dividend payments follow a chronological order of events, and the associated dates are important to determine the shareholders who qualify for receiving the dividend payment. Balchem one year expected dividend income is about $0.17 per share.
The current year Dividend Yield is expected to grow to 0.005921, whereas Payment of Dividends and Other Cash Distributions is forecasted to decline to (17.1 M).
Last ReportedProjected for 2021
Payment of Dividends and Other Cash Distributions-16.7 M-17.1 M
Dividend Yield 0.00575  0.005921 
Dividends per Basic Common Share 0.58  0.51 
Investing in stocks that pay dividends, such as stock of Balchem Cp, is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Balchem Cp must own a stock before its ex-dividend date to receive its next dividend.
This type of analysis is very useful when you want to generate a past dividend schedule and payout information for Balchem Cp. Then that information in the form of graph and calendar can be used to fully explain how Du Pont dividends can provide a real clue to its valuation.

How Balchem utilizes its cash?

To perform a cash flow analysis of Balchem Cp, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Balchem Cp is receiving and how much cash it distributes out in a given period. The Balchem Cp cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.
Balchem Cp Net Cash Flow from Operations is projected to increase significantly based on the last few years of reporting. The past year's Net Cash Flow from Operations was at 150.49 Million

Balchem Cp Gross Profit

Balchem Cp Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Balchem Cp previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Balchem Cp Gross Profit growth over the last 10 years.
Please check Gross Profit in more details.

Payment of 548 shares by John Televantos of Balchem Cp subject to Rule 16b-3

Legal trades by Balchem Cp insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
Balchem insider trading alert for payment of common stock by John Televantos, the corporate stakeholder, on 23rd of February 2021. This event was filed by Balchem Corp with SEC on 2021-02-23. Statement of changes in beneficial ownership - SEC Form 4 [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

What is the case for Balchem Cp Investors

There are few distinct groups of Balchem Cp stakehholders that the SEC considers insiders. Investors usually gain information through their work as corporate directors, officers, or employees. If these individuals share the information with a friend, family, or business partner and the person who receives the information exchanges stock in the company, he or shie is also an insider. Let's take a look at how the ownership of Balchem is distributed among investors.

Ownership Allocation

Balchem Cp retains a total of 32.35 Million outstanding shares. The majority of Balchem Cp outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Balchem Cp to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Balchem Cp. Please pay attention to any change in the institutional holdings of Balchem Cp as this could imply that something significant has changed or about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.

Retail Investors
11.92%
Institutions
87.33%
Retail Investors11.92
Insiders0.75
Institutions87.33
 2018 2019 2020 2021 (projected)
Consolidated Income78.57 M79.67 M91.62 M81.44 M
Direct Expenses439.43 M432.34 M389.1 M342.69 M

Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Balchem Cp has an asset utilization ratio of 78.24 percent. This suggests that the company is making $0.78 for each dollar of assets. An increasing asset utilization means that Balchem Cp is more efficient with each dollar of assets it utilizes for everyday operations.

Assets Non Current
831 M
Goodwill
615.2 M
Current Assets272.63 Million15.8
Assets Non Current830.98 Million48.17
Goodwill615.15 Million35.66
Tax Assets6.33 Million0.37

Balchem Cp is projected to stay under $117 in March

Current Information Ratio is up to 0.01. Price may slip again. Balchem Cp has relatively low volatility with skewness of 0.61 and kurtosis of 4.02. However, we advise all investors to independently investigate Balchem Cp to ensure all accessible information is consistent with the expectations about its upside potential and future expected returns.

Whereas other entities under the specialty chemicals industry are still a bit expensive, Balchem Cp may offer a potential longer-term growth to investors. On the whole, as of the 19th of February 2021, we see that Balchem Cp responds to the market. The company is fairly valued with very low probability of distress within the next 24 months. Our concluding 30 days recommendation on the company is Strong Hold.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Balchem Cp. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com